Cargando…
Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer
INTRODUCTION: Mutational inactivation of the FBXW7/hCDC4 tumor suppressor gene (TSG) is common in many cancer types, but infrequent in breast cancers. This study investigates the presence and impact of FBXW7/hCDC4 promoter methylation in breast cancer. METHODS: FBXW7/hCDC4-β expression and promoter...
Autores principales: | Akhoondi, Shahab, Lindström, Linda, Widschwendter, Martin, Corcoran, Martin, Bergh, Jonas, Spruck, Charles, Grandér, Dan, Sangfelt, Olle |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046450/ https://www.ncbi.nlm.nih.gov/pubmed/21122106 http://dx.doi.org/10.1186/bcr2788 |
Ejemplares similares
-
FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients
por: Hagedorn, Martin, et al.
Publicado: (2007) -
Fbw7/hCDC4 dimerization regulates its substrate interactions
por: Welcker, Markus, et al.
Publicado: (2007) -
Mutation Analysis of hCDC4 in AML Cells Identifies a New Intronic Polymorphism
por: Nowak, Daniel, et al.
Publicado: (2006) -
Chromosomal instability and lack of cyclin E regulation in hCdc4 mutant human breast cancer cells
por: Willmarth, Nicole E, et al.
Publicado: (2004) -
Maximizing Production of Human Interferon-γ in HCDC of Recombinant E. coli
por: Babaeipour, Valiollah, et al.
Publicado: (2013)